Clinical Perspectives

Ovarian Transposition an Option for Fertility Preservation for Some Cervical Cancer Patients

For young women with cervical cancer, the possibility of losing the ability to have children can be a particularly challenging part of their...

Phase 1 Study Evaluating the Combination of 3 Immunotherapies in Metastatic HER2-Positive Breast Cancer Patients

Moffitt's Breast Oncology team assess a new Phase 1 HER2+ metastatic breast cancer trial combining T cell therapy following HER2-pulsed dendritic...

Knowing When Minimally Invasive Cancer Surgery is the Best Treatment Option Can Saves Lives

It’s vital that cancer surgeons understand when minimally invasive cancer surgery procedures are optimal for their patients and when they are not.

Predicting IPMN Pathology Using Noninvasive Radiogenomics

Dr. Jennifer Permuth is leading a study funded by the National Cancer Institute on early detection and prevention related to intraductal papillary...

Q&A: Dr. Mok Shares His Role as an Advanced Endoscopist

Dr. Shaffer Mok, a gastroenterologist and advanced endoscopist, shares advancements in the treatment of gastrointestinal cancers.

Phase 1 Trial: Evaluating Claudin18.2-Specific CAR T Cells in Gastrointestinal Cancers

A phase 1 clinical trial evaluates the effectiveness of CLDN18.2-targeted CAR-T cells in digestive system cancers.

Identification of Targetable Gene Fusions Present in KRASWT Pancreatic Adenocarcinoma and the Response to Targeted Therapy

Study shows Oncogene fusions are present in KRASWT pancreatic adenocarcinomas at an increased frequency when compared with KRASMUT pancreatic...

A New Approach to Cancer Diagnostics

Moffitt's Diagnostic Imaging and Interventional Radiology Program provides the highest level of diagnosis services resulting in the most effective...

5-ALA is Transforming the Treatment of Glioblastoma

By enhancing a surgeon’s ability to clearly visualize the boundaries of the tumor, 5-ALA-guided tumor resection can provide a tremendous advantage.

Innovative Margin Assessment Technology Presents Positive Outcomes in Breast Cancer Surgery

Moffitt's Dr. Marie Lee tests the effectiveness of the SELENE System on positive margin rates in breast lumpectomy surgery for cancer.

Moffitt Connecting National Experts for Myeloma Immunotherapy Breakthroughs

The Multiple Myeloma Cellular Therapy Consortium, an alliance of CAR T-cell therapy programs nationwide, has created the largest cohort of multiple...

Using CUE-101 in Combination with Pembrolizumab in Treating Recurrent/Metastatic HPV16+ Head and Neck Cancer

Dr. Chung presents her research findings at SITC when combining CUE-101 with Pembrolizumab, a monotherapy in treating HPV16+ recurrent/metastatic...

Dr. Ahmed Tests the Response of Systemic Therapies or Radiation Across Different Metastatic Disease Sites

Study presented at 2022 ASTRO presents outcomes of systemic therapies or radiation across various metastatic disease sites.

MRgSBRT Demonstrates Advantages in Treatment for Adrenal Gland Metastases

Magnetic resonance guided SBRT (MRgSBRT) shows better response than CT-based stereotactic body radiation therapy (SGRT) in treating adrenal gland...

8 Reasons to Consider Clinical Trials First

For patients facing cancer, their first chance is their best chance, and that means considering all options at the time of diagnosis, including...